Harnessing the Stem Cell Potential: A case for neural stem cell therapy

Nature Medicine

Volumn 19, Issue 12, 2013, Pages 1580-1581

  Yang, Nan ^a   Wernig, Marius ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DISEASE; GENE PRODUCT; GRAFT REJECTION; HUMAN; METABOLIC DISORDER; MULTIPLE SCLEROSIS; MYELINATION; NERVE CONDUCTION; NERVE DEGENERATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NOTE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REMYELINIZATION;

EID: 84889858682     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3425     Document Type: Note

References (10)

1. Inoue, K. et al. Ann. Neurol. 45, 624-632 (1999).
2. Franklin, R.J. & Ffrench-Constant, C. Nat. Rev. Neurosci. 9, 839-855 (2008).
3. Sim, F.J. et al. Nat. Biotechnol. 29, 934-941 (2011).
4. Windrem, M.S. et al. Cell Stem Cell 2, 553-565 (2008).
5. Uchida, N. et al. Sci. Transl. Med. 4, 155ra136 (2012).
6. Gupta, N. et al. Sci. Transl. Med. 4, 155ra137 (2012).
7. Potts, M.B., Silvestrini, M.T. & Lim, D.A. Surg. Neurol. Int. 4, S22-S30 (2013).
8. Wang, S. et al. Cell Stem Cell 12, 252-264 (2013).
9. Yang, N. et al. Nat. Biotechnol. 31, 434-439 (2013).
10. Najm, F.J. et al. Nat. Biotechnol. 31, 426-433 (2013).